Morpholine → HCID 59489700, compound

HRID 1808044Notes

Reaction equation

HRID 1808044 reaction equation
CS(O[CH2:6][CH2:7][C:8]1[CH:13]=[CH:12][C:11]([NH:14][C:15]2[N:24]=[CH:23][C:22]3[CH2:21][C@H:20]([C:25]4[CH:30]=[CH:29][C:28]([Cl:31])=[C:27]([Cl:32])[CH:26]=4)[C:19]4[CH:33]=[CH:34][CH:35]=[CH:36][C:18]=4[C:17]=3[N:16]=2)=[CH:10][CH:9]=1)(=O)=O.[NH:37]1[CH2:42][CH2:41][O:40][CH2:39][CH2:38]1>>[Cl:32][C:27]1[CH:26]=[C:25]([C@@H:20]2[C:19]3[CH:33]=[CH:34][CH:35]=[CH:36][C:18]=3[C:17]3[N:16]=[C:15]([NH:14][C:11]4[CH:10]=[CH:9][C:8]([CH2:7][CH2:6][N:37]5[CH2:42][CH2:41][O:40][CH2:39][CH2:38]5)=[CH:13][CH:12]=4)[N:24]=[CH:23][C:22]=3[CH2:21]2)[CH:30]=[CH:29][C:28]=1[Cl:31]

Participants

3

Procedure

This product was synthesized as described in general procedure 2 except (R)-4-(6-(3,4-dichlorophenyl)-5,6-dihydrobenzo[h]quinazolin-2-ylamino)phenethyl methanesulfonate was used instead of 4-(6-(3-bromophenyl)-5,6-dihydrobenzo[h]quinazolin-2-ylamino)phenethyl methanesulfonate and morpholine was used instead of piperidine to afford the title compound in 45% yield. M.p.=166-167° C. 1H NMR 400 MHz (CDCl3) δ 8.41 (dd, J=1.6 Hz, 7.6 Hz, 1H), 8.18 (s, 1H), 7.65-7.61 (m, 2H), 7.49-7.39 (m, 2H), 7.32 (d, J=8.4 Hz, 1H), 7.25-7.19 (m, 3H), 7.09 (s, 1H), 7.03-6.99 (m, 1H), 6.91 (dd, J=2.4 Hz, 8.4 Hz, 1H), 4.29-4.24 (m, 1H), 3.79-3.74 (m, 4H), 3.21 (dd, J=6.0 Hz, 15.6 Hz, 1H), 3.04 (dd, J=7.2 Hz, 15.6 Hz, 1H), 2.83-2.77 (m, 2H), 2.64-2.51 (m, 6H). LCMS m/e 531 (M+H).

Workup

  1. customThis product was synthesized

Sources & evidence

ORD record
ord-e2f88fd09af24ff4b704c34c9b04089f
Source dataset
uspto-grants-2013_01
Patent number
US08357694B2

Reaction notes

Loading…